X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (19678) 19678
Journal Article (2117) 2117
Trade Publication Article (1034) 1034
Publication (274) 274
Book / eBook (164) 164
Report (45) 45
Web Resource (45) 45
Book Chapter (37) 37
Book Review (37) 37
Magazine Article (13) 13
Government Document (11) 11
Conference Proceeding (9) 9
Data Set (3) 3
Dissertation (3) 3
Paper (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
net losses (16917) 16917
financial performance (11455) 11455
research & development--r&d (8399) 8399
stockholders (5642) 5642
administrative expenses (5597) 5597
net income (5367) 5367
clinical trials (5281) 5281
pharmaceutical industry (4611) 4611
investments (4318) 4318
earnings per share (4272) 4272
income taxes (3271) 3271
equity (3236) 3236
shareholders equity (3213) 3213
webcasting (3163) 3163
acquisitions & mergers (3134) 3134
current liabilities (2591) 2591
collaboration (2484) 2484
product development (2469) 2469
corporate profits (2342) 2342
fda approval (2199) 2199
regulatory approval (2068) 2068
compensation (1971) 1971
patients (1872) 1872
costs (1766) 1766
humans (1577) 1577
earnings (1464) 1464
index medicus (1417) 1417
sales (1375) 1375
pharmaceuticals (1295) 1295
marketing (1248) 1248
drug dosages (1224) 1224
appointments & personnel changes (1219) 1219
stock exchanges (1216) 1216
studies (1212) 1212
manufacturing (1151) 1151
agreements (1064) 1064
company sales and earnings (1049) 1049
cancer (1018) 1018
oncology (969) 969
tax rates (965) 965
consolidated financial statements (937) 937
biotechnology industry (879) 879
medical research (863) 863
capital expenditures (856) 856
web sites (838) 838
fiscal years (825) 825
royalties (821) 821
candidates (806) 806
female (805) 805
inventory (782) 782
chief executive officers (771) 771
cancer therapies (765) 765
male (756) 756
cash flow (750) 750
intellectual property (718) 718
capital losses (697) 697
cost control (685) 685
laboratories (676) 676
deferred income (664) 664
tumors (651) 651
diabetes (646) 646
profit margins (626) 626
profitability (618) 618
patents (613) 613
medical equipment (607) 607
deferred income taxes (596) 596
breast cancer (587) 587
fair value (581) 581
accounts payable (578) 578
preferred stock (578) 578
safe harbor (562) 562
wages & salaries (554) 554
market positioning (551) 551
metastasis (551) 551
copyright (545) 545
business metrics (532) 532
balance sheets (528) 528
life sciences (524) 524
working capital (522) 522
boards of directors (516) 516
long term debt (513) 513
research & development expenditures (509) 509
research (505) 505
litigation (501) 501
adult (497) 497
immunotherapy (487) 487
disease (485) 485
stock prices (478) 478
medicine (462) 462
chemotherapy (457) 457
proprietary (450) 450
stock options (447) 447
product lines (442) 442
infectious diseases (436) 436
liability (436) 436
prostate cancer (432) 432
pharmacy (428) 428
revenue recognition (424) 424
middle aged (421) 421
accounting policies (412) 412
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (71) 71
Robarts - Stacks (27) 27
Collection Dvlpm't (Acquisitions) - Vendor file (21) 21
UTL at Downsview - May be requested (14) 14
UofT at Scarborough - Stacks (14) 14
Engineering & Comp. Sci. - Stacks (13) 13
UofT at Mississauga - Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
OISE - Stacks (5) 5
Online Resources - Online (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Trinity College (John W Graham) - Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Business (Joseph L Rotman) - Searching (1) 1
Business (Joseph L Rotman) - Stacks (1) 1
Criminology - Stacks (1) 1
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Gerstein Science - Reference (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Innis College - Stacks (1) 1
Mathematical Sciences - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Searching (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Stacks (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23122) 23122
Spanish (16) 16
Japanese (13) 13
German (11) 11
French (7) 7
Portuguese (3) 3
Chinese (2) 2
Czech (2) 2
Hebrew (1) 1
Nepali (1) 1
Polish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American Journal of Medicine, ISSN 0002-9343, 06/2019, Volume 132, Issue 6, pp. 749 - 757.e5
The risks of thromboembolic and hemorrhagic events in patients with atrial fibrillation both increase with age; therefore, net clinical benefit analyses of... 
NOACs | Cardiovascular events | Net clinical benefit | Atrial fibrillation | Elderly | Major bleeding | VKAs | DEFINITION | METAANALYSIS | MANAGEMENT | STROKE PREVENTION | EFFICACY | SAFETY | MEDICINE, GENERAL & INTERNAL | THERAPY | EUROPEAN COUNTRIES | WARFARIN | ORAL ANTICOAGULANTS
Journal Article
Heart Rhythm, ISSN 1547-5271, 01/2019, Volume 16, Issue 1, pp. 31 - 37
Oral anticoagulation (OAC) is effective in stroke prevention in elderly patients with nonvalvular atrial fibrillation (AF), but older patients are also at... 
Net clinical benefit | Intracranial hemorrhage | Stroke | Anticoagulation | Elderly | Atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | STROKE PREVENTION | BLEEDING RISK | DABIGATRAN | WARFARIN | ORAL ANTICOAGULANTS
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 04/2018, Volume 257, pp. 78 - 83
The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban compared with warfarin in patients with atrial fibrillation. This was a... 
Rivaroxaban | Net clinical benefit | Atrial fibrillation | STROKE | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | PREVENTION | ANTICOAGULATION | Stroke (Disease) | Warfarin | Comparative analysis | Singers
Journal Article
Frontiers in pharmacology, ISSN 1663-9812, 2018, Volume 9, p. 575
Venous thromboembolism (VTE) is highly prevalent in patients with cancer. Non-vitamin K antagonist oral anticoagulants (NOACs), directly targeting the... 
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2014, Volume 23, Issue 5, pp. 1142 - 1147
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 01/2015, Volume 65, Issue 3, pp. 225 - 232
Journal Article